6-33425806-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006772.3(SYNGAP1):​c.198C>T​(p.Pro66Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00866 in 1,613,860 control chromosomes in the GnomAD database, including 1,104 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. P66P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.044 ( 522 hom., cov: 31)
Exomes 𝑓: 0.0050 ( 582 hom. )

Consequence

SYNGAP1
NM_006772.3 synonymous

Scores

3

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.108

Publications

1 publications found
Variant links:
Genes affected
SYNGAP1 (HGNC:11497): (synaptic Ras GTPase activating protein 1) This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
SYNGAP1 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • intellectual disability, autosomal dominant 5
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant non-syndromic intellectual disability
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • SYNGAP1-related developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • myoclonic-astatic epilepsy
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_006772.3, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant 6-33425806-C-T is Benign according to our data. Variant chr6-33425806-C-T is described in ClinVar as Benign. ClinVar VariationId is 130527.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.108 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.15 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_006772.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYNGAP1
NM_006772.3
MANE Select
c.198C>Tp.Pro66Pro
synonymous
Exon 3 of 19NP_006763.2A0A1U9X8L0
SYNGAP1
NM_001130066.2
c.198C>Tp.Pro66Pro
synonymous
Exon 3 of 18NP_001123538.1B7ZCA0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SYNGAP1
ENST00000646630.1
MANE Select
c.198C>Tp.Pro66Pro
synonymous
Exon 3 of 19ENSP00000496007.1Q96PV0-1
SYNGAP1
ENST00000644458.1
c.198C>Tp.Pro66Pro
synonymous
Exon 3 of 19ENSP00000495541.1A0A2R8Y6T2
SYNGAP1
ENST00000449372.7
TSL:5
c.198C>Tp.Pro66Pro
synonymous
Exon 3 of 18ENSP00000416519.4B7ZCA0

Frequencies

GnomAD3 genomes
AF:
0.0439
AC:
6678
AN:
152020
Hom.:
521
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.153
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0165
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00637
Gnomad NFE
AF:
0.000529
Gnomad OTH
AF:
0.0321
GnomAD2 exomes
AF:
0.0118
AC:
2930
AN:
248962
AF XY:
0.00876
show subpopulations
Gnomad AFR exome
AF:
0.162
Gnomad AMR exome
AF:
0.00667
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000385
Gnomad OTH exome
AF:
0.00361
GnomAD4 exome
AF:
0.00498
AC:
7282
AN:
1461728
Hom.:
582
Cov.:
32
AF XY:
0.00426
AC XY:
3098
AN XY:
727158
show subpopulations
African (AFR)
AF:
0.176
AC:
5889
AN:
33478
American (AMR)
AF:
0.00718
AC:
321
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000904
AC:
78
AN:
86252
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53392
Middle Eastern (MID)
AF:
0.00937
AC:
54
AN:
5762
European-Non Finnish (NFE)
AF:
0.000338
AC:
376
AN:
1111932
Other (OTH)
AF:
0.00934
AC:
564
AN:
60384
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
341
682
1024
1365
1706
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
190
380
570
760
950
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0440
AC:
6692
AN:
152132
Hom.:
522
Cov.:
31
AF XY:
0.0428
AC XY:
3184
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.153
AC:
6328
AN:
41450
American (AMR)
AF:
0.0165
AC:
252
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4820
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10610
Middle Eastern (MID)
AF:
0.00685
AC:
2
AN:
292
European-Non Finnish (NFE)
AF:
0.000530
AC:
36
AN:
67988
Other (OTH)
AF:
0.0318
AC:
67
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
275
549
824
1098
1373
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
68
136
204
272
340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0172
Hom.:
98
Bravo
AF:
0.0511
Asia WGS
AF:
0.00664
AC:
24
AN:
3478
EpiCase
AF:
0.000709
EpiControl
AF:
0.000474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not specified (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
Intellectual disability, autosomal dominant 5 (1)
-
-
1
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
12
DANN
Benign
0.88
PhyloP100
-0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs73402305;
hg19: chr6-33393583;
COSMIC: COSV53387883;
COSMIC: COSV53387883;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.